Search research articles
Contact Us
Filters
Showing results (271-280 of 276) with videos related to
Page
of 28
Sort By:
You have reached the last page of results.
This site can display upto 276 results.
The Lancet. Oncology
|
January 25, 2022
Ibrutinib-rituximab followed by R-HCVAD as frontline treatment for young patients (≤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial
Michael L Wang, Preetesh Jain, Shuangtao Zhao, et al.
Blood Advances
|
March 20, 2020
Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL
Preetesh Jain, Shaojun Zhang, Rashmi Kanagal-Shamanna, et al.
American Journal of Hematology
|
April 3, 2020
Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients
Shuangtao Zhao, Rashmi Kanagal-Shamanna, Lucy Navsaria, et al.
Blood Cancer Discovery
|
January 26, 2026
Incorporation of genomic determinants improves diagnostic accuracy of oligomonocytic chronic myelomonocytic leukemia
Guillermo Montalban-Bravo, Chong Wu, Juan Jose Rodriguez-Sevilla, et al.
Frontiers in Immunology
|
May 21, 2021
Metabolic Reprogramming of GMP Grade Cord Tissue Derived Mesenchymal Stem Cells Enhances Their Suppressive Potential in GVHD
Mayela Mendt, May Daher, Rafet Basar, et al.
Blood Cancer Discovery
|
May 9, 2022
Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma
Neeraj Y Saini, David M Swoboda, Uri Greenbaum, et al.
Page
of 28
Search research articles
Search
Showing results (271-280 of 276) with videos related to
Sort By:
Page
of 28
You have reached the last page of results.
This site can display upto 276 results.
The Lancet. Oncology
|
January 25, 2022
Ibrutinib-rituximab followed by R-HCVAD as frontline treatment for young patients (≤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial
Michael L Wang, Preetesh Jain, Shuangtao Zhao, et al.
Blood Advances
|
March 20, 2020
Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL
Preetesh Jain, Shaojun Zhang, Rashmi Kanagal-Shamanna, et al.
American Journal of Hematology
|
April 3, 2020
Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients
Shuangtao Zhao, Rashmi Kanagal-Shamanna, Lucy Navsaria, et al.
Blood Cancer Discovery
|
January 26, 2026
Incorporation of genomic determinants improves diagnostic accuracy of oligomonocytic chronic myelomonocytic leukemia
Guillermo Montalban-Bravo, Chong Wu, Juan Jose Rodriguez-Sevilla, et al.
Frontiers in Immunology
|
May 21, 2021
Metabolic Reprogramming of GMP Grade Cord Tissue Derived Mesenchymal Stem Cells Enhances Their Suppressive Potential in GVHD
Mayela Mendt, May Daher, Rafet Basar, et al.
Blood Cancer Discovery
|
May 9, 2022
Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma
Neeraj Y Saini, David M Swoboda, Uri Greenbaum, et al.
Page
of 28